Bench to Bedside Speakers
Suchismita Acharya, PhD
CEO, AyuVis Research Inc
Assistant Professor, North Texas Eye Research Institute
Pharmacology & Neuroscience, UNT Health Science Center
Thomas W. Chalberg, PhD
Founder, Polymerase Capital
Founder, Exhaura Ltd.
Executive Chairman, iRenix
Louis C. Cullman, Esq.
Partner, K&L Gates, LLP
Alon Harris, MS, PhD, FARVO
Department of Ophthalmology, Icahn School of Medicine at Mount Sinai
Thurein Htoo, MS, MBS
Qlaris Bio, Inc.
Starlight Bio, Inc.
Darius Kharabi, JD, MBA
Chief Business Officer at Kala Pharmaceuticals
Saho Murakami, MD
Office of New Drug Ⅲ, Pharmaceuticals and Medical Devices Agency (PMDA)
Tieuvi Nguyen, PhD
Director, Division of Ophthalmic Devices, FDA
Susan Orr
CMO, Claris Biotherapeutics
Hema Ramkumar, MD
CEO, Oculogenex
Stella Robertson, PhD, FARVO
Arrochar Consulting, LLC; Bios Partners, LP
Cynthia A. Toth, MD
Joseph AC Wadsworth Professor of Ophthalmology and Professor of Biomedical Engineering, Duke University
Chief Medical Officer, Theia Imaging LLC